Our anti-HIV jab will be rolled out in six weeks. But funding cuts hollowed out the system needed to deliver it
The Mail & Guardian | 22.04.2026 20:39
The uptake of the once-every-six-month HIV prevention jab lenacapavir (LEN) in South Africa will be heavily affected by the Trump administration’s funding cuts to the country, a new report has found.
